Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
No data support the efficacy of currently marketed patches
For a buyer, the practical point is clear
Completion of the trials main phase is expected in September 2025, and the 52-week extension (in which participants and investigators remain blinded to treatment assignment) will continue to October 2026
In this blog, well explore the science behind BPC-157, its benefits for soft tissue repair, and its role in managing inflammation, supported by the latest research and clinical studies
doi: 10.1159/000297775
US$ 26.66
US$ 28.24
US$ 27.57
